The START Center - San Antonio
South Texas Accelerated Research Therapeutics
San Antonio, TX
Accepting patients
MOMENTUM
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
- IKZF1/3
- Phase 2
Accepting patients
QXL138AM
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Masked Immunocytokine (MIC)
- CD138
- Phase 1